Global Spinal Fusion Biologics Supply, Demand and Key Producers, 2024-2030

Page: 137

Published Date: 13 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Spinal Fusion Biologics market size is expected to reach $ 3055.7 million by 2030, rising at a market growth of 4.8% CAGR during the forecast period (2024-2030).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.

This report studies the global Spinal Fusion Biologics production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Spinal Fusion Biologics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Spinal Fusion Biologics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Spinal Fusion Biologics total production and demand, 2019-2030, (K Units)
Global Spinal Fusion Biologics total production value, 2019-2030, (USD Million)
Global Spinal Fusion Biologics production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Spinal Fusion Biologics consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Spinal Fusion Biologics domestic production, consumption, key domestic manufacturers and share
Global Spinal Fusion Biologics production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Spinal Fusion Biologics production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Spinal Fusion Biologics production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Spinal Fusion Biologics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine and K2M, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Spinal Fusion Biologics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Spinal Fusion Biologics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Spinal Fusion Biologics Market, Segmentation by Type
    Bone Graft
    Bone Graft Substitute
    Platelet Rich Plasma (PRP)
    Other

Global Spinal Fusion Biologics Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    Medtronic
    J & J
    Stryker Corporation
    Nuvasive
    Zimmer Biomet
    Orthofix International
    Globus Medical
    alphatec spine
    K2M
    Exactech
    Wright Medical Technology
    X-Spine
    Nutech
    Arthrex

Key Questions Answered
1. How big is the global Spinal Fusion Biologics market?
2. What is the demand of the global Spinal Fusion Biologics market?
3. What is the year over year growth of the global Spinal Fusion Biologics market?
4. What is the production and production value of the global Spinal Fusion Biologics market?
5. Who are the key producers in the global Spinal Fusion Biologics market?

Table of Contents

1 Supply Summary
    1.1 Spinal Fusion Biologics Introduction
    1.2 World Spinal Fusion Biologics Supply & Forecast
        1.2.1 World Spinal Fusion Biologics Production Value (2019 & 2023 & 2030)
        1.2.2 World Spinal Fusion Biologics Production (2019-2030)
        1.2.3 World Spinal Fusion Biologics Pricing Trends (2019-2030)
    1.3 World Spinal Fusion Biologics Production by Region (Based on Production Site)
        1.3.1 World Spinal Fusion Biologics Production Value by Region (2019-2030)
        1.3.2 World Spinal Fusion Biologics Production by Region (2019-2030)
        1.3.3 World Spinal Fusion Biologics Average Price by Region (2019-2030)
        1.3.4 North America Spinal Fusion Biologics Production (2019-2030)
        1.3.5 Europe Spinal Fusion Biologics Production (2019-2030)
        1.3.6 China Spinal Fusion Biologics Production (2019-2030)
        1.3.7 Japan Spinal Fusion Biologics Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Spinal Fusion Biologics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Spinal Fusion Biologics Major Market Trends

2 Demand Summary
    2.1 World Spinal Fusion Biologics Demand (2019-2030)
    2.2 World Spinal Fusion Biologics Consumption by Region
        2.2.1 World Spinal Fusion Biologics Consumption by Region (2019-2024)
        2.2.2 World Spinal Fusion Biologics Consumption Forecast by Region (2025-2030)
    2.3 United States Spinal Fusion Biologics Consumption (2019-2030)
    2.4 China Spinal Fusion Biologics Consumption (2019-2030)
    2.5 Europe Spinal Fusion Biologics Consumption (2019-2030)
    2.6 Japan Spinal Fusion Biologics Consumption (2019-2030)
    2.7 South Korea Spinal Fusion Biologics Consumption (2019-2030)
    2.8 ASEAN Spinal Fusion Biologics Consumption (2019-2030)
    2.9 India Spinal Fusion Biologics Consumption (2019-2030)

3 World Spinal Fusion Biologics Manufacturers Competitive Analysis
    3.1 World Spinal Fusion Biologics Production Value by Manufacturer (2019-2024)
    3.2 World Spinal Fusion Biologics Production by Manufacturer (2019-2024)
    3.3 World Spinal Fusion Biologics Average Price by Manufacturer (2019-2024)
    3.4 Spinal Fusion Biologics Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Spinal Fusion Biologics Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Spinal Fusion Biologics in 2023
        3.5.3 Global Concentration Ratios (CR8) for Spinal Fusion Biologics in 2023
    3.6 Spinal Fusion Biologics Market: Overall Company Footprint Analysis
        3.6.1 Spinal Fusion Biologics Market: Region Footprint
        3.6.2 Spinal Fusion Biologics Market: Company Product Type Footprint
        3.6.3 Spinal Fusion Biologics Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Spinal Fusion Biologics Production Value Comparison
        4.1.1 United States VS China: Spinal Fusion Biologics Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Spinal Fusion Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Spinal Fusion Biologics Production Comparison
        4.2.1 United States VS China: Spinal Fusion Biologics Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Spinal Fusion Biologics Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Spinal Fusion Biologics Consumption Comparison
        4.3.1 United States VS China: Spinal Fusion Biologics Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Spinal Fusion Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Spinal Fusion Biologics Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Spinal Fusion Biologics Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Spinal Fusion Biologics Production (2019-2024)
    4.5 China Based Spinal Fusion Biologics Manufacturers and Market Share
        4.5.1 China Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Spinal Fusion Biologics Production Value (2019-2024)
        4.5.3 China Based Manufacturers Spinal Fusion Biologics Production (2019-2024)
    4.6 Rest of World Based Spinal Fusion Biologics Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Spinal Fusion Biologics Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Spinal Fusion Biologics Production (2019-2024)

5 Market Analysis by Type
    5.1 World Spinal Fusion Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Bone Graft
        5.2.2 Bone Graft Substitute
        5.2.3 Platelet Rich Plasma (PRP)
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Spinal Fusion Biologics Production by Type (2019-2030)
        5.3.2 World Spinal Fusion Biologics Production Value by Type (2019-2030)
        5.3.3 World Spinal Fusion Biologics Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Spinal Fusion Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Spinal Fusion Biologics Production by Application (2019-2030)
        6.3.2 World Spinal Fusion Biologics Production Value by Application (2019-2030)
        6.3.3 World Spinal Fusion Biologics Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Details
        7.1.2 Medtronic Major Business
        7.1.3 Medtronic Spinal Fusion Biologics Product and Services
        7.1.4 Medtronic Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Medtronic Recent Developments/Updates
        7.1.6 Medtronic Competitive Strengths & Weaknesses
    7.2 J & J
        7.2.1 J & J Details
        7.2.2 J & J Major Business
        7.2.3 J & J Spinal Fusion Biologics Product and Services
        7.2.4 J & J Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 J & J Recent Developments/Updates
        7.2.6 J & J Competitive Strengths & Weaknesses
    7.3 Stryker Corporation
        7.3.1 Stryker Corporation Details
        7.3.2 Stryker Corporation Major Business
        7.3.3 Stryker Corporation Spinal Fusion Biologics Product and Services
        7.3.4 Stryker Corporation Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Stryker Corporation Recent Developments/Updates
        7.3.6 Stryker Corporation Competitive Strengths & Weaknesses
    7.4 Nuvasive
        7.4.1 Nuvasive Details
        7.4.2 Nuvasive Major Business
        7.4.3 Nuvasive Spinal Fusion Biologics Product and Services
        7.4.4 Nuvasive Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Nuvasive Recent Developments/Updates
        7.4.6 Nuvasive Competitive Strengths & Weaknesses
    7.5 Zimmer Biomet
        7.5.1 Zimmer Biomet Details
        7.5.2 Zimmer Biomet Major Business
        7.5.3 Zimmer Biomet Spinal Fusion Biologics Product and Services
        7.5.4 Zimmer Biomet Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Zimmer Biomet Recent Developments/Updates
        7.5.6 Zimmer Biomet Competitive Strengths & Weaknesses
    7.6 Orthofix International
        7.6.1 Orthofix International Details
        7.6.2 Orthofix International Major Business
        7.6.3 Orthofix International Spinal Fusion Biologics Product and Services
        7.6.4 Orthofix International Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Orthofix International Recent Developments/Updates
        7.6.6 Orthofix International Competitive Strengths & Weaknesses
    7.7 Globus Medical
        7.7.1 Globus Medical Details
        7.7.2 Globus Medical Major Business
        7.7.3 Globus Medical Spinal Fusion Biologics Product and Services
        7.7.4 Globus Medical Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Globus Medical Recent Developments/Updates
        7.7.6 Globus Medical Competitive Strengths & Weaknesses
    7.8 alphatec spine
        7.8.1 alphatec spine Details
        7.8.2 alphatec spine Major Business
        7.8.3 alphatec spine Spinal Fusion Biologics Product and Services
        7.8.4 alphatec spine Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 alphatec spine Recent Developments/Updates
        7.8.6 alphatec spine Competitive Strengths & Weaknesses
    7.9 K2M
        7.9.1 K2M Details
        7.9.2 K2M Major Business
        7.9.3 K2M Spinal Fusion Biologics Product and Services
        7.9.4 K2M Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 K2M Recent Developments/Updates
        7.9.6 K2M Competitive Strengths & Weaknesses
    7.10 Exactech
        7.10.1 Exactech Details
        7.10.2 Exactech Major Business
        7.10.3 Exactech Spinal Fusion Biologics Product and Services
        7.10.4 Exactech Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Exactech Recent Developments/Updates
        7.10.6 Exactech Competitive Strengths & Weaknesses
    7.11 Wright Medical Technology
        7.11.1 Wright Medical Technology Details
        7.11.2 Wright Medical Technology Major Business
        7.11.3 Wright Medical Technology Spinal Fusion Biologics Product and Services
        7.11.4 Wright Medical Technology Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Wright Medical Technology Recent Developments/Updates
        7.11.6 Wright Medical Technology Competitive Strengths & Weaknesses
    7.12 X-Spine
        7.12.1 X-Spine Details
        7.12.2 X-Spine Major Business
        7.12.3 X-Spine Spinal Fusion Biologics Product and Services
        7.12.4 X-Spine Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 X-Spine Recent Developments/Updates
        7.12.6 X-Spine Competitive Strengths & Weaknesses
    7.13 Nutech
        7.13.1 Nutech Details
        7.13.2 Nutech Major Business
        7.13.3 Nutech Spinal Fusion Biologics Product and Services
        7.13.4 Nutech Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Nutech Recent Developments/Updates
        7.13.6 Nutech Competitive Strengths & Weaknesses
    7.14 Arthrex
        7.14.1 Arthrex Details
        7.14.2 Arthrex Major Business
        7.14.3 Arthrex Spinal Fusion Biologics Product and Services
        7.14.4 Arthrex Spinal Fusion Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Arthrex Recent Developments/Updates
        7.14.6 Arthrex Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Spinal Fusion Biologics Industry Chain
    8.2 Spinal Fusion Biologics Upstream Analysis
        8.2.1 Spinal Fusion Biologics Core Raw Materials
        8.2.2 Main Manufacturers of Spinal Fusion Biologics Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Spinal Fusion Biologics Production Mode
    8.6 Spinal Fusion Biologics Procurement Model
    8.7 Spinal Fusion Biologics Industry Sales Model and Sales Channels
        8.7.1 Spinal Fusion Biologics Sales Model
        8.7.2 Spinal Fusion Biologics Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Spinal Fusion Biologics Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Spinal Fusion Biologics Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Spinal Fusion Biologics Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Spinal Fusion Biologics Production Value Market Share by Region (2019-2024)
    Table 5. World Spinal Fusion Biologics Production Value Market Share by Region (2025-2030)
    Table 6. World Spinal Fusion Biologics Production by Region (2019-2024) & (K Units)
    Table 7. World Spinal Fusion Biologics Production by Region (2025-2030) & (K Units)
    Table 8. World Spinal Fusion Biologics Production Market Share by Region (2019-2024)
    Table 9. World Spinal Fusion Biologics Production Market Share by Region (2025-2030)
    Table 10. World Spinal Fusion Biologics Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Spinal Fusion Biologics Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Spinal Fusion Biologics Major Market Trends
    Table 13. World Spinal Fusion Biologics Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Spinal Fusion Biologics Consumption by Region (2019-2024) & (K Units)
    Table 15. World Spinal Fusion Biologics Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Spinal Fusion Biologics Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Spinal Fusion Biologics Producers in 2023
    Table 18. World Spinal Fusion Biologics Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Spinal Fusion Biologics Producers in 2023
    Table 20. World Spinal Fusion Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Spinal Fusion Biologics Company Evaluation Quadrant
    Table 22. World Spinal Fusion Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Spinal Fusion Biologics Production Site of Key Manufacturer
    Table 24. Spinal Fusion Biologics Market: Company Product Type Footprint
    Table 25. Spinal Fusion Biologics Market: Company Product Application Footprint
    Table 26. Spinal Fusion Biologics Competitive Factors
    Table 27. Spinal Fusion Biologics New Entrant and Capacity Expansion Plans
    Table 28. Spinal Fusion Biologics Mergers & Acquisitions Activity
    Table 29. United States VS China Spinal Fusion Biologics Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Spinal Fusion Biologics Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Spinal Fusion Biologics Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Spinal Fusion Biologics Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Spinal Fusion Biologics Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Spinal Fusion Biologics Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Spinal Fusion Biologics Production Market Share (2019-2024)
    Table 37. China Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Spinal Fusion Biologics Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Spinal Fusion Biologics Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Spinal Fusion Biologics Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Spinal Fusion Biologics Production Market Share (2019-2024)
    Table 42. Rest of World Based Spinal Fusion Biologics Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Spinal Fusion Biologics Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Spinal Fusion Biologics Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Spinal Fusion Biologics Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Spinal Fusion Biologics Production Market Share (2019-2024)
    Table 47. World Spinal Fusion Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Spinal Fusion Biologics Production by Type (2019-2024) & (K Units)
    Table 49. World Spinal Fusion Biologics Production by Type (2025-2030) & (K Units)
    Table 50. World Spinal Fusion Biologics Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Spinal Fusion Biologics Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Spinal Fusion Biologics Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Spinal Fusion Biologics Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Spinal Fusion Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Spinal Fusion Biologics Production by Application (2019-2024) & (K Units)
    Table 56. World Spinal Fusion Biologics Production by Application (2025-2030) & (K Units)
    Table 57. World Spinal Fusion Biologics Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Spinal Fusion Biologics Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Spinal Fusion Biologics Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Spinal Fusion Biologics Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Medtronic Basic Information, Manufacturing Base and Competitors
    Table 62. Medtronic Major Business
    Table 63. Medtronic Spinal Fusion Biologics Product and Services
    Table 64. Medtronic Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Medtronic Recent Developments/Updates
    Table 66. Medtronic Competitive Strengths & Weaknesses
    Table 67. J & J Basic Information, Manufacturing Base and Competitors
    Table 68. J & J Major Business
    Table 69. J & J Spinal Fusion Biologics Product and Services
    Table 70. J & J Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. J & J Recent Developments/Updates
    Table 72. J & J Competitive Strengths & Weaknesses
    Table 73. Stryker Corporation Basic Information, Manufacturing Base and Competitors
    Table 74. Stryker Corporation Major Business
    Table 75. Stryker Corporation Spinal Fusion Biologics Product and Services
    Table 76. Stryker Corporation Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Stryker Corporation Recent Developments/Updates
    Table 78. Stryker Corporation Competitive Strengths & Weaknesses
    Table 79. Nuvasive Basic Information, Manufacturing Base and Competitors
    Table 80. Nuvasive Major Business
    Table 81. Nuvasive Spinal Fusion Biologics Product and Services
    Table 82. Nuvasive Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Nuvasive Recent Developments/Updates
    Table 84. Nuvasive Competitive Strengths & Weaknesses
    Table 85. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
    Table 86. Zimmer Biomet Major Business
    Table 87. Zimmer Biomet Spinal Fusion Biologics Product and Services
    Table 88. Zimmer Biomet Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Zimmer Biomet Recent Developments/Updates
    Table 90. Zimmer Biomet Competitive Strengths & Weaknesses
    Table 91. Orthofix International Basic Information, Manufacturing Base and Competitors
    Table 92. Orthofix International Major Business
    Table 93. Orthofix International Spinal Fusion Biologics Product and Services
    Table 94. Orthofix International Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Orthofix International Recent Developments/Updates
    Table 96. Orthofix International Competitive Strengths & Weaknesses
    Table 97. Globus Medical Basic Information, Manufacturing Base and Competitors
    Table 98. Globus Medical Major Business
    Table 99. Globus Medical Spinal Fusion Biologics Product and Services
    Table 100. Globus Medical Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Globus Medical Recent Developments/Updates
    Table 102. Globus Medical Competitive Strengths & Weaknesses
    Table 103. alphatec spine Basic Information, Manufacturing Base and Competitors
    Table 104. alphatec spine Major Business
    Table 105. alphatec spine Spinal Fusion Biologics Product and Services
    Table 106. alphatec spine Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. alphatec spine Recent Developments/Updates
    Table 108. alphatec spine Competitive Strengths & Weaknesses
    Table 109. K2M Basic Information, Manufacturing Base and Competitors
    Table 110. K2M Major Business
    Table 111. K2M Spinal Fusion Biologics Product and Services
    Table 112. K2M Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. K2M Recent Developments/Updates
    Table 114. K2M Competitive Strengths & Weaknesses
    Table 115. Exactech Basic Information, Manufacturing Base and Competitors
    Table 116. Exactech Major Business
    Table 117. Exactech Spinal Fusion Biologics Product and Services
    Table 118. Exactech Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Exactech Recent Developments/Updates
    Table 120. Exactech Competitive Strengths & Weaknesses
    Table 121. Wright Medical Technology Basic Information, Manufacturing Base and Competitors
    Table 122. Wright Medical Technology Major Business
    Table 123. Wright Medical Technology Spinal Fusion Biologics Product and Services
    Table 124. Wright Medical Technology Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Wright Medical Technology Recent Developments/Updates
    Table 126. Wright Medical Technology Competitive Strengths & Weaknesses
    Table 127. X-Spine Basic Information, Manufacturing Base and Competitors
    Table 128. X-Spine Major Business
    Table 129. X-Spine Spinal Fusion Biologics Product and Services
    Table 130. X-Spine Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. X-Spine Recent Developments/Updates
    Table 132. X-Spine Competitive Strengths & Weaknesses
    Table 133. Nutech Basic Information, Manufacturing Base and Competitors
    Table 134. Nutech Major Business
    Table 135. Nutech Spinal Fusion Biologics Product and Services
    Table 136. Nutech Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Nutech Recent Developments/Updates
    Table 138. Arthrex Basic Information, Manufacturing Base and Competitors
    Table 139. Arthrex Major Business
    Table 140. Arthrex Spinal Fusion Biologics Product and Services
    Table 141. Arthrex Spinal Fusion Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 142. Global Key Players of Spinal Fusion Biologics Upstream (Raw Materials)
    Table 143. Spinal Fusion Biologics Typical Customers
    Table 144. Spinal Fusion Biologics Typical Distributors
List of Figure
    Figure 1. Spinal Fusion Biologics Picture
    Figure 2. World Spinal Fusion Biologics Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Spinal Fusion Biologics Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Spinal Fusion Biologics Production (2019-2030) & (K Units)
    Figure 5. World Spinal Fusion Biologics Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Spinal Fusion Biologics Production Value Market Share by Region (2019-2030)
    Figure 7. World Spinal Fusion Biologics Production Market Share by Region (2019-2030)
    Figure 8. North America Spinal Fusion Biologics Production (2019-2030) & (K Units)
    Figure 9. Europe Spinal Fusion Biologics Production (2019-2030) & (K Units)
    Figure 10. China Spinal Fusion Biologics Production (2019-2030) & (K Units)
    Figure 11. Japan Spinal Fusion Biologics Production (2019-2030) & (K Units)
    Figure 12. Spinal Fusion Biologics Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 15. World Spinal Fusion Biologics Consumption Market Share by Region (2019-2030)
    Figure 16. United States Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 17. China Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 18. Europe Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 19. Japan Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 22. India Spinal Fusion Biologics Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Spinal Fusion Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Spinal Fusion Biologics Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Spinal Fusion Biologics Markets in 2023
    Figure 26. United States VS China: Spinal Fusion Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Spinal Fusion Biologics Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Spinal Fusion Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Spinal Fusion Biologics Production Market Share 2023
    Figure 30. China Based Manufacturers Spinal Fusion Biologics Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Spinal Fusion Biologics Production Market Share 2023
    Figure 32. World Spinal Fusion Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Spinal Fusion Biologics Production Value Market Share by Type in 2023
    Figure 34. Bone Graft
    Figure 35. Bone Graft Substitute
    Figure 36. Platelet Rich Plasma (PRP)
    Figure 37. Other
    Figure 38. World Spinal Fusion Biologics Production Market Share by Type (2019-2030)
    Figure 39. World Spinal Fusion Biologics Production Value Market Share by Type (2019-2030)
    Figure 40. World Spinal Fusion Biologics Average Price by Type (2019-2030) & (US$/Unit)
    Figure 41. World Spinal Fusion Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Spinal Fusion Biologics Production Value Market Share by Application in 2023
    Figure 43. Hospital
    Figure 44. Clinic
    Figure 45. Other
    Figure 46. World Spinal Fusion Biologics Production Market Share by Application (2019-2030)
    Figure 47. World Spinal Fusion Biologics Production Value Market Share by Application (2019-2030)
    Figure 48. World Spinal Fusion Biologics Average Price by Application (2019-2030) & (US$/Unit)
    Figure 49. Spinal Fusion Biologics Industry Chain
    Figure 50. Spinal Fusion Biologics Procurement Model
    Figure 51. Spinal Fusion Biologics Sales Model
    Figure 52. Spinal Fusion Biologics Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex

Related Reports

Global Spinal Fusion Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Spinal Fusion Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Medical Devices & Consumables

Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.

Global Spinal Fusion Biologics Supply, Demand and Key Producers, 2023-2029

Global Spinal Fusion Biologics Supply, Demand and Key Producers, 2023-2029

date 28 Jan 2023

date Medical Devices & Consumables

The global Spinal Fusion Biologics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Spinal Fusion Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Spinal Fusion Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Spinal Fusion Biologics market size was valued at USD 2203 million in 2023 and is forecast to a readjusted size of USD 3055.7 million by 2030 with a CAGR of 4.8% during review period.

Product Tags

Spinal Fusion Biologics

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>